SlideShare uma empresa Scribd logo
1 de 16
European Union action  in the field of newborn screening for some rare diseases Amsterdam, 14th May 2011   Antoni Montserrat Moliner Policy Officer for Rare Diseases DG SANCO Health Information Unit  European Commission
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DG SANCO priorities on rare diseases Web site   Public health actions http:// ec.europa.eu/health/rare_diseases/policy/index_en.htm Contact point at DG SANCO [email_address] Research actions http://ec.europa.eu/research/health/medical-research/rare-diseases/index_en.html Contact point at DG RTD [email_address]

Mais conteúdo relacionado

Mais procurados

Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"EURORDIS - Rare Diseases Europe
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"EURORDIS - Rare Diseases Europe
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"EURORDIS - Rare Diseases Europe
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...EURORDIS - Rare Diseases Europe
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsEUPATI
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...Nowgen
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1EUPATI
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceDutch Orphan Drug Network
 

Mais procurados (20)

Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
Workshop 6 - "BURQOL-RD"
Workshop 6 - "BURQOL-RD"Workshop 6 - "BURQOL-RD"
Workshop 6 - "BURQOL-RD"
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
 
Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"Workshop 6 - "Case study: Italian Training for MDs,"
Workshop 6 - "Case study: Italian Training for MDs,"
 
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
Workshop 6 - "Sharing expertise: transfer of experience from patient organiza...
 
Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"Workshop 7 - "Folic acid prevents neural tubes defect"
Workshop 7 - "Folic acid prevents neural tubes defect"
 
Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"Workshop 6 - "Feedback from the 15 National Conferences"
Workshop 6 - "Feedback from the 15 National Conferences"
 
Jornadas #PatientInHTA · Iñaki Imaz
Jornadas #PatientInHTA · Iñaki ImazJornadas #PatientInHTA · Iñaki Imaz
Jornadas #PatientInHTA · Iñaki Imaz
 
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
Workshop 7 - "Presentation of the International Federation for Spina Bifida a...
 
Introduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentationsIntroduction to the breakout sessions & case studies presentations
Introduction to the breakout sessions & case studies presentations
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1
 
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to li...
 
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
EUPATI 2013 Conference: Building Knowledge & Competences for Patients’ Involv...
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task Force
 

Semelhante a EU action in newborn screening for rare diseases

European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesPlan de Calidad para el SNS
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Mihaiela Fazacas
 
EU Pharmacovigilance legislation
EU Pharmacovigilance legislation EU Pharmacovigilance legislation
EU Pharmacovigilance legislation Arete-Zoe, LLC
 
Insights: EU Healthcare Policy March 2013
Insights: EU Healthcare Policy March 2013Insights: EU Healthcare Policy March 2013
Insights: EU Healthcare Policy March 2013MSL
 
Respiratory Diseases in European Health Priorities during the Polish Presiden...
Respiratory Diseases in European Health Priorities during the Polish Presiden...Respiratory Diseases in European Health Priorities during the Polish Presiden...
Respiratory Diseases in European Health Priorities during the Polish Presiden...Global Risk Forum GRFDavos
 
Ec hiv actionplan_2014_en
Ec hiv actionplan_2014_enEc hiv actionplan_2014_en
Ec hiv actionplan_2014_enIllia Luzan
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCittadinanzattiva onlus
 
ECC Call to Action 010915_Print
ECC Call to Action 010915_PrintECC Call to Action 010915_Print
ECC Call to Action 010915_PrintJules Gaughan
 
EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docx
EN    EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docxEN    EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docx
EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docxSALU18
 
Gesamt publikation understanding the pharmaceutical care concept and applying...
Gesamt publikation understanding the pharmaceutical care concept and applying...Gesamt publikation understanding the pharmaceutical care concept and applying...
Gesamt publikation understanding the pharmaceutical care concept and applying...nuretampan
 
Marcella Marletta - EU HTA Cooperation Answering National Needs
Marcella Marletta - EU HTA Cooperation Answering National NeedsMarcella Marletta - EU HTA Cooperation Answering National Needs
Marcella Marletta - EU HTA Cooperation Answering National NeedsMarcella Marletta
 

Semelhante a EU action in newborn screening for rare diseases (20)

Session 25 antoni_montserrat
Session 25 antoni_montserratSession 25 antoni_montserrat
Session 25 antoni_montserrat
 
Antoni Montserrat
Antoni MontserratAntoni Montserrat
Antoni Montserrat
 
European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare Diseases
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009
 
Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)
 
Session 2 terkel_andersen
Session 2 terkel_andersenSession 2 terkel_andersen
Session 2 terkel_andersen
 
Lee Mc Gill
Lee Mc GillLee Mc Gill
Lee Mc Gill
 
Session 25 andrzej_rys
Session 25 andrzej_rysSession 25 andrzej_rys
Session 25 andrzej_rys
 
EU Pharmacovigilance legislation
EU Pharmacovigilance legislation EU Pharmacovigilance legislation
EU Pharmacovigilance legislation
 
Insights: EU Healthcare Policy March 2013
Insights: EU Healthcare Policy March 2013Insights: EU Healthcare Policy March 2013
Insights: EU Healthcare Policy March 2013
 
Update: National Plans for Rare Diseases
Update: National Plans for Rare Diseases Update: National Plans for Rare Diseases
Update: National Plans for Rare Diseases
 
Respiratory Diseases in European Health Priorities during the Polish Presiden...
Respiratory Diseases in European Health Priorities during the Polish Presiden...Respiratory Diseases in European Health Priorities during the Polish Presiden...
Respiratory Diseases in European Health Priorities during the Polish Presiden...
 
Ec hiv actionplan_2014_en
Ec hiv actionplan_2014_enEc hiv actionplan_2014_en
Ec hiv actionplan_2014_en
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD Coalition
 
ECC Call to Action 010915_Print
ECC Call to Action 010915_PrintECC Call to Action 010915_Print
ECC Call to Action 010915_Print
 
EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docx
EN    EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docxEN    EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docx
EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docx
 
Julio E. Celis-Investigar, educar, dialogar
Julio E. Celis-Investigar, educar, dialogarJulio E. Celis-Investigar, educar, dialogar
Julio E. Celis-Investigar, educar, dialogar
 
Gesamt publikation understanding the pharmaceutical care concept and applying...
Gesamt publikation understanding the pharmaceutical care concept and applying...Gesamt publikation understanding the pharmaceutical care concept and applying...
Gesamt publikation understanding the pharmaceutical care concept and applying...
 
Presentation1
Presentation1Presentation1
Presentation1
 
Marcella Marletta - EU HTA Cooperation Answering National Needs
Marcella Marletta - EU HTA Cooperation Answering National NeedsMarcella Marletta - EU HTA Cooperation Answering National Needs
Marcella Marletta - EU HTA Cooperation Answering National Needs
 

Mais de EURORDIS - Rare Diseases Europe

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...EURORDIS - Rare Diseases Europe
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseEURORDIS - Rare Diseases Europe
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgEURORDIS - Rare Diseases Europe
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyEURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...EURORDIS - Rare Diseases Europe
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...EURORDIS - Rare Diseases Europe
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"EURORDIS - Rare Diseases Europe
 
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...EURORDIS - Rare Diseases Europe
 

Mais de EURORDIS - Rare Diseases Europe (19)

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
 
RareConnect.org Update 2016
RareConnect.org Update 2016RareConnect.org Update 2016
RareConnect.org Update 2016
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.org
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
 
Conference 3 "Outcomes of 15 National Conferences, "
Conference 3   "Outcomes of 15 National Conferences, "Conference 3   "Outcomes of 15 National Conferences, "
Conference 3 "Outcomes of 15 National Conferences, "
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
 
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
Workshop 4 - "Presentation of the RD Platform fact finding study on the trend...
 

EU action in newborn screening for rare diseases

  • 1. European Union action in the field of newborn screening for some rare diseases Amsterdam, 14th May 2011 Antoni Montserrat Moliner Policy Officer for Rare Diseases DG SANCO Health Information Unit European Commission
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. DG SANCO priorities on rare diseases Web site Public health actions http:// ec.europa.eu/health/rare_diseases/policy/index_en.htm Contact point at DG SANCO [email_address] Research actions http://ec.europa.eu/research/health/medical-research/rare-diseases/index_en.html Contact point at DG RTD [email_address]